Thus, anti-VEGF treatment restored the tissue TSP-1 levels and improved the pulmonary microvascular phenotype in Eng+/- and Alk1+/- mice, while it prevented and halted the generation of AVMs in the Alk1 iKOe model of HHT. This evidence concerns the gene THBS1 and hereditary hemorrhagic telangiectasia.